Cargando…
Is Procalcitonin Useful in Pediatric Critical Care Patients?
This review examines the use of procalcitonin in different clinical situations in the pediatric patient, with special emphasis on those requiring intensive care. We review the latest articles on its potency as a biomarker in both infectious processes at diagnosis and on the response to treatment.
Autores principales: | Bobillo-Perez, Sara, Rodríguez-Fanjul, Javier, Jordan Garcia, Iolanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081751/ https://www.ncbi.nlm.nih.gov/pubmed/30093797 http://dx.doi.org/10.1177/1177271918792244 |
Ejemplares similares
-
Kinetics of Procalcitonin in Pediatric Patients on Extracorporeal Membrane Oxygenation
por: Bobillo, Sara, et al.
Publicado: (2018) -
Procalcitonin and lung ultrasound algorithm to diagnose severe pneumonia in critical paediatric patients (PROLUSP study). A randomised clinical trial
por: Rodríguez-Fanjul, Javier, et al.
Publicado: (2020) -
Procalcitonin Is a Better Biomarker than C-Reactive Protein in Newborns Undergoing Cardiac Surgery: The PROKINECA Study
por: Pérez, Sara Bobillo, et al.
Publicado: (2016) -
A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker
por: Solé-Ribalta, Anna, et al.
Publicado: (2022) -
Antimicrobial stewardship, procalcitonin testing, and rapid blood-culture identification to optimize sepsis care in critically ill adult patients: A quality improvement initiative
por: Sligl, Wendy I., et al.
Publicado: (2023)